Table 7.

Malignancies after hemopoietic stem cell transplantation.

Donor
MalignancyAllogeneic RelatedAllogeneic UnrelatedSyngeneicAutologousTotal
*Observed among 9,029 patients transplanted at the Fred Hutchinson Cancer Research Center as of 12/31/00. 
Thyroid and other locations. 
Abbreviations: CA, carcinoma; MDS, myelodysplastic syndrome; AML, acute myelogenous leukemia; ALL, acute lymphoblastic leukemia; Neuro. Misc., miscellaneous tumors of the nervous system; PTLD, posttransplant lymphoproliferative disorder. 
Basal cell CA 47 63 
Squamous cell CA 37 10  49 
Adeno CA 25 42 
PTLD 22   25 
Hodgkin    
Malignant melanoma  
Papillary CAs 11 
Mucoepidermoid CA   
Renal cell CA  
Glioblastoma/astrocytoma 10 
Fibrous histiocytoma (liver)    
Sarcoma  
MDS  
AML   
ALL   
Neuro. misc.    
Other   
Total 180 36 11 31 258 
No. pts. transplanted 5093 520 250 2166 9029 
Donor
MalignancyAllogeneic RelatedAllogeneic UnrelatedSyngeneicAutologousTotal
*Observed among 9,029 patients transplanted at the Fred Hutchinson Cancer Research Center as of 12/31/00. 
Thyroid and other locations. 
Abbreviations: CA, carcinoma; MDS, myelodysplastic syndrome; AML, acute myelogenous leukemia; ALL, acute lymphoblastic leukemia; Neuro. Misc., miscellaneous tumors of the nervous system; PTLD, posttransplant lymphoproliferative disorder. 
Basal cell CA 47 63 
Squamous cell CA 37 10  49 
Adeno CA 25 42 
PTLD 22   25 
Hodgkin    
Malignant melanoma  
Papillary CAs 11 
Mucoepidermoid CA   
Renal cell CA  
Glioblastoma/astrocytoma 10 
Fibrous histiocytoma (liver)    
Sarcoma  
MDS  
AML   
ALL   
Neuro. misc.    
Other   
Total 180 36 11 31 258 
No. pts. transplanted 5093 520 250 2166 9029 

or Create an Account

Close Modal
Close Modal